Trial Profile
Efficacy and safety of Duodopa in patients with advanced Parkinson's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2021
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms GLORIA
- Sponsors AbbVie
- 19 Jun 2018 Results of a post-hoc analysis presented at the 4th Congress of the European Academy of Neurology
- 27 Apr 2018 Results assessing the safety of Levodopa/carbidopa Intestinal Gel using data from this study and other phase III studies, presented at the 70th Annual Meeting of the American Academy of Neurology
- 27 Apr 2018 Results of post- hoc analysis from the GLORIA registry presented at the 70th Annual Meeting of the American Academy of Neurology